)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
NRx Pharmaceuticals
NRx Pharmaceuticals (NRXP) investor relations material
NRx Pharmaceuticals Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary5 Nov, 2026
Executive summary
Annual meeting scheduled for Dec. 17, 2026, at 10:00 a.m. ET; the Board recommends voting FOR both proposals.
Voting matters and shareholder proposals
Shareholders will vote on Dennis McBride’s election as a director and ratification of Weinberg & Company P.A. as independent auditor for FY 2026.
Board of directors and corporate governance
Dennis McBride is the Board’s nominee for election.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from NRx Pharmaceuticals
- Two proposals, a classified Board and detailed related-party oversight shape the 2026 meeting.NRXP
Proxy filing - FDA approval advances preservative-free ketamine toward U.S. launch amid shortages.NRXPFDA announcement
- Preservative-free ketamine and robotic TMS drive innovation, with FDA decision expected soon.NRXP12th Annual Cantor Fitzgerald Global Healthcare Conference
- Monoclonal antibody for ALS enters production, with clinical trials targeted for 2027.NRXPMoody Capital Disruptive Growth & Life Science Conference
- FDA review nearly complete; five million units prepared to address U.S. ketamine shortage.NRXPStatus update
- Regulatory advances, asset acquisition, and $22.3M funding drive growth and clinical expansion.NRXPQ2 2026
- Net loss fell to $1.4M as clinical revenue began and regulatory, clinic, and asset advances accelerated.NRXPQ1 2026
- Advanced drug filings, expanded clinics, improved finances, but funding risks persist.NRXPQ1 2025
- Losses narrowed, NDA filings advanced, and clinic network expansion underway.NRXPQ4 2024
Next NRx Pharmaceuticals earnings date
Q3 202617 Nov, 2026
NRx Pharmaceuticals
Next NRx Pharmaceuticals earnings date
Q3 202617 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
NRx Pharmaceuticals Inc. (NRXP) is a clinical-stage pharmaceutical company focused on developing novel therapeutics for the treatment of central nervous system disorders. The company's portfolio includes ZYESAMI, an investigational drug for COVID-19 related respiratory failure, and oral therapeutics NRX-100 and NRX-101 for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company is headquartered in Wilmington, Delaware, and its shares are listed on the Nasdaq.